Oncology Consortium

Impactful Education Through Innovative Engagement

roy.berger@theoncologyconsortium.com | (516) 729-0303

Robert G. Maki, MD, PhD, FACP

Pediatric Oncology and Sarcoma Consortium

Robert Maki is Professor in the Departments of Medicine and Orthopaedics, and also Section Chief in Pediatric Hematology-Oncology at Tisch Cancer Institute, Mt Sinai Medical Center in New York. He trained at Dana Farber Cancer Center and worked there as well as becoming Section Chief of the Adult Sarcoma Division at MSKCC with an Appointment as Associate Professor at Cornell University, Weill Medical College.

Richard F. Riedel, MD

Sarcoma Consortium

Dr. Riedel is an Associate Professor in the Division of Medical Oncology at Duke University Medical Center and Associate Director for Clinical and Translational Research for the Duke Sarcoma Program, within the Duke Cancer Institute.

Scott Schuetze, MD, PhD

Sarcoma Consortium

Dr. Scott Schuetze is a Clinical Professor, Department of Internal Medicine. He received his MD and PhD from Oregon Health Sciences University in 1993. Dr. Schuetze completed his residency at Duke University Medical Center in 1996. His Oncology Fellowship followed at Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA.

Jonathan C. Trent, MD, PhD

Sarcoma Consortium

Dr. Jonathan C. Trent earned his undergraduate degree in chemistry at Southeastern Oklahoma State University and his MD and PhD in cancer biology from The University of Texas Health Science Center. He completed an internship and residency in internal medicine at The University of Texas Health Science Center, and a fellowship in medical oncology at The University of Texas M. D. Anderson Cancer Center while serving as chief fellow. Prior to joining the University of Miami, Miller School of Medicine, he held appointments as faculty of the University of Texas Graduate School of Biomedical Sciences at Houston, and Associate Professor of Medicine in the Department of Sarcoma Medical Oncology, Division of Cancer Medicine at the University of Texas M.D. Anderson Cancer Center in Houston. Dr. Trent is currently the Associate Director for Clinical Research for the Sylvester Comprehensive Cancer Center, the Co-Director of the Musculoskeletal Center, and the Director for Bone and Soft-tissue Sarcoma.


Download Capability Slide
Oncology Consortium | All Rights Reserved 2012-2017
Back to Top